HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 280, Issue 15, 15004-15012, April 15, 2005

This Article Full Text Full Text (PDF) All Versions of this Article: 280/15/15004    most recent M500962200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Johnson, K. A. Articles by Terkeltaub, R. A. Search for Related Content PubMed PubMed Citation Articles by Johnson, K. A. Articles by Terkeltaub, R. A. Social Bookmarking                      What's this?

External GTP-bound Transglutaminase 2 Is a Molecular Switch for Chondrocyte Hypertrophic Differentiation and Calcification^*

Kristen A. Johnson and Robert A. Terkeltaub

From the Veterans Affairs Medical Center, University of California, San Diego, La Jolla, California 92161

Chondrocyte maturation to hypertrophy, associated with up-regulated transglutaminase 2 (TG2) expression, mediates not only physiologic growth plate mineralization but also pathologic matrix calcification and dys-regulated matrix repair in osteoarthritic articular cartilage. TG2–/– mouse chondrocytes demonstrate markedly inhibited progression to hypertrophic differentiation in response to both retinoic acid and the chemokine CXCL1. Here, our objectives were to test if up-regulated TG2 alone is sufficient to promote chondrocyte hypertrophic differentiation and to identify TG2 molecular determinants and potential downstream signals involved. TG2 activities, regulated by nucleotides and calcium, include cross-linking of cartilage matrix proteins, binding of fibronectin, and hydrolysis of GTP and ATP. Following transfection of TG2 site-directed mutants into chondrocytic cells, we observed that wild type TG2, and TG catalytic site and fibronectin-binding mutants promoted type X collagen expression and matrix calcification consistent with chondrocyte hypertrophic differentiation. In contrast, transfected mutants of TG2 GTP binding (K173L) and externalization (Y274A) sites did not stimulate chondrocyte hypertrophy. Recombinant TG2 treatment of bovine cartilage explants demonstrated that extracellular TG2 induced hypertrophy more robustly in the GTP-bound state, confirming an essential role of TG2 GTP binding. Finally, TG2 treatment induced type X collagen in a 1 integrin-mediated manner, associated with rapid phosphorylation of both Rac1 and p38 kinases that were inhibited by mutation of the TG2 GTP binding site. In conclusion, externalized GTP-bound TG2 serves as a molecular switch for differentiation of chondrocytes to a hypertrophic, calcifying phenotype in a manner that does not require either TG2 transamidation activity or fibronectin binding.

Received for publication, January 26, 2005

^* This work was supported by grants from the Department of Veterans Affairs and the National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Veterans Affairs Medical Center, 3350 La Jolla Village Dr., San Diego, CA 92161. Tel.: 858-552-8585 (ext. 3519); Fax: 858-552-7425; E-mail: rterkeltaub{at}ucsd.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. A. Johnson, D. M. Rose, and R. A. Terkeltaub Factor XIIIA mobilizes transglutaminase 2 to induce chondrocyte hypertrophic differentiation J. Cell Sci., July 1, 2008; 121(13): 2256 - 2264. [Abstract] [Full Text] [PDF]

				D. L. Cecil and R. Terkeltaub Transamidation by Transglutaminase 2 Transforms S100A11 Calgranulin into a Procatabolic Cytokine for Chondrocytes J. Immunol., June 15, 2008; 180(12): 8378 - 8385. [Abstract] [Full Text] [PDF]

				E. VanBavel and E. N.T.P. Bakker A Vascular Bone Collector: Arterial Calcification Requires Tissue-Type Transglutaminase Circ. Res., March 14, 2008; 102(5): 507 - 509. [Full Text] [PDF]

				K. A. Johnson, M. Polewski, and R. A. Terkeltaub Transglutaminase 2 Is Central to Induction of the Arterial Calcification Program by Smooth Muscle Cells Circ. Res., March 14, 2008; 102(5): 529 - 537. [Abstract] [Full Text] [PDF]

				Y. Nakano, H. F. Al-Jallad, A. Mousa, and M. T. Kaartinen Expression and Localization of Plasma Transglutaminase Factor XIIIA in Bone J. Histochem. Cytochem., July 1, 2007; 55(7): 675 - 685. [Abstract] [Full Text] [PDF]

				Y. Zhang, M. A. Brown, C. Peach, G. Russell, and B. P. Wordsworth Investigation of the role of ENPP1 and TNAP genes in chondrocalcinosis Rheumatology, April 1, 2007; 46(4): 586 - 589. [Abstract] [Full Text] [PDF]

				W. Wang and T. Kirsch Annexin V/beta5 Integrin Interactions Regulate Apoptosis of Growth Plate Chondrocytes J. Biol. Chem., October 13, 2006; 281(41): 30848 - 30856. [Abstract] [Full Text] [PDF]

				Y. Wang, S. Nishida, T. Sakata, H. Z. Elalieh, W. Chang, B. P. Halloran, S. B. Doty, and D. D. Bikle Insulin-Like Growth Factor-I Is Essential for Embryonic Bone Development Endocrinology, October 1, 2006; 147(10): 4753 - 4761. [Abstract] [Full Text] [PDF]

				S. Mishra, A. Saleh, P. S. Espino, J. R. Davie, and L. J. Murphy Phosphorylation of Histones by Tissue Transglutaminase J. Biol. Chem., March 3, 2006; 281(9): 5532 - 5538. [Abstract] [Full Text] [PDF]

				D. L. Cecil, K. Johnson, J. Rediske, M. Lotz, A. M. Schmidt, and R. Terkeltaub Inflammation-Induced Chondrocyte Hypertrophy Is Driven by Receptor for Advanced Glycation End Products J. Immunol., December 15, 2005; 175(12): 8296 - 8302. [Abstract] [Full Text] [PDF]